Skip to main content
Clinical Trials/NCT00731068
NCT00731068CompletedPhase 2

PRP as a Treatment for ACHILLES Tendon Tears - Randomized-Double-Blind-Placebo Control Trail

Meir Medical Center0 sites50 target enrollmentStarted: February 2007Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
50
Primary Endpoint
improvement of symptoms / disease progress

Study Overview

Brief Summary

To review the influence of patient derived PRGF on the healing process of Achilles tendon after a surgical correction of a complete tear.

Detailed Description

Autologous platelet-rich matrices may aid in post surgical patients by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • A complete tear of Achilles tendon
  • Age 18-50 years old

Exclusion Criteria

  • under 18 year of age
  • pregnancy
  • physical or mental disabilities

Outcomes

Primary Outcomes

improvement of symptoms / disease progress

Time Frame: 1 year

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials